JAK2 and thrombocytosis disease: JAK2 mutations were enriched in both cases with isolated thrombocytosis (10.3% vs 1.4%; P = 0.002) as well as in cases carrying an additional cytosis (26.9% vs 0.0%; P = 0.010) compared with their respective matched controls (Suppl.